- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about SDGR
Recent news which mentions SDGR
Why These 7 Healthcare Stocks Could Soar in 2023
January 02, 2023
From InvestorPlace
7 Drug Stocks That Will Soar in 2023
December 22, 2022
From InvestorPlace
Why OpGen Shares Are Trading Higher By 220%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session
December 13, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Monday
December 05, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Friday
December 02, 2022
From Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
November 28, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Monday
November 28, 2022
From Benzinga
Yelp, Twilio, Atlassian, And Other Big Losers From Friday
November 07, 2022
From Benzinga
From Benzinga
3 Hypergrowth Stocks That Will Make You a Millionaire by 2027
November 04, 2022
From InvestorPlace
Stocks That Hit 52-Week Lows On Friday
November 04, 2022
From Benzinga
Earnings Scheduled For November 3, 2022
November 03, 2022
From Benzinga
7 Small-Cap Stock Picks to Beat the September Market Slump
September 15, 2022
From InvestorPlace
From Benzinga
Geoffrey Porges has been named CFO of Schrodinger Inc. (SDGR). SDGR is currently trading at $28.07 per share.
August 18, 2022
Tickers
SDGR
From Best Stocks
Schrödinger, Inc. (SDGR) Q2 2022 Earnings Call Transcript
August 05, 2022
Tickers
SDGR
From Motley Fool
3 Biotech Stocks to Buy on the Dip
July 21, 2022
From InvestorPlace
The 7 Best Stocks to Buy on a Dip in July
July 14, 2022
From InvestorPlace
From InvestorPlace
Tickers
SDGR
From Motley Fool
AI Pharma Startup METiS Raises $150 Million. IPO In Sight?
April 12, 2022
From Benzinga
Schrödinger New Preclinical Data Supports Development Of Its Wee1 Inhibitor In Cancer Indications
April 12, 2022
Tickers
SDGR
From Benzinga
From Benzinga
3 Hypergrowth Tech Stocks to Buy for Huge Upside Potential
April 07, 2022
From InvestorPlace
From Benzinga
93 Biggest Movers From Friday
February 28, 2022
From Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
February 25, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.